×
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
NYSE:MDT

Medtronic Stock Forecast, Price & News

$91.38
+1.63 (+1.82%)
(As of 07/1/2022 03:59 PM ET)
Add
Compare
Today's Range
$89.08
$91.54
50-Day Range
$87.40
$107.15
52-Week Range
$86.95
$135.89
Volume
306,056 shs
Average Volume
5.93 million shs
Market Capitalization
$122.59 billion
P/E Ratio
24.50
Dividend Yield
2.98%
Price Target
$121.55

Medtronic MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.52 Rating Score
Upside/​Downside
33.0% Upside
$121.55 Price Target
Short Interest
Healthy
0.76% of Float Sold Short
Dividend Strength
Strong
Based on Four Factors
Sustainability
-0.81
Upright™ Environmental Score
News Sentiment
0.42mentions of Medtronic in the last 14 days
Based on 4 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
8.45%
From $5.56 to $6.03 Per Share

Overall MarketRank

MarketRank is calculated as 30% analysis score, 20% valuation score, 10% short interest score, 10% dividend score, 10% sustainability score, 10% news and social score, and 10% insider trading score.

3.12 out of 5 stars

Medical Sector

4th out of 1,428 stocks

Electromedical Equipment Industry

1st out of 30 stocks

30 days | 90 days | 365 days | Advanced Chart

Receive MDT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Medtronic and its competitors with MarketBeat's FREE daily newsletter.

Medtronic logo

About Medtronic (NYSE:MDT) Stock

Medtronic plc develops, manufactures, distributes, and sells device-based medical therapies to hospitals, physicians, clinicians, and patients worldwide. It operates through four segments: Cardiovascular Portfolio, Neuroscience Portfolio, Medical Surgical Portfolio, and Diabetes Operating Unit. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; AF ablation products; insertable cardiac monitor systems; mechanical circulatory support; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves; percutaneous coronary intervention stents, surgical valve replacement and repair products, endovascular stent grafts, percutaneous angioplasty balloons, and products to treat superficial venous diseases in the lower extremities. The Medical Surgical Portfolio segment offers surgical products, including surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases. The Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The Diabetes Operating Unit segment offers insulin pumps and consumables, and continuous glucose monitoring systems. The company was founded in 1949 and is headquartered in Dublin, Ireland.

MDT Stock News Headlines

These 3 Stocks Have Plenty of Room to Run
Medtronic plc (MDT) To Go Ex-Dividend on June 23rd
Will Medtronic Stock See Higher Levels?
See More Headlines

Industry, Sector and Symbol

Industry
Electromedical equipment
Sub-Industry
Health Care Equipment
Sector
Medical
CUSIP
58505510
Employees
95,000
Year Founded
1949

Company Calendar

Ex-Dividend for 4/22 Dividend
3/24/2022
Dividend Payable
4/22/2022
Last Earnings
5/26/2022
Ex-Dividend for 7/15 Dividend
6/23/2022
Today
7/05/2022
Dividend Payable
7/15/2022
Next Earnings (Estimated)
8/23/2022
Fiscal Year End
4/30/2023

Price Target and Rating

Average Stock Price Forecast
$121.55
High Stock Price Forecast
$165.00
Low Stock Price Forecast
$100.00
Forecasted Upside/Downside
+33.0%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.52380952380952
Research Coverage
21 Analysts

Profitability

Net Income
$5.04 billion
Pretax Margin
17.41%

Debt

Sales & Book Value

Annual Sales
$31.69 billion
Cash Flow
$7.62 per share
Book Value
$39.30 per share

Miscellaneous

Outstanding Shares
1,341,540,000
Free Float
1,335,234,000
Market Cap
$122.59 billion
Optionable
Optionable
Beta
0.77

Social Links















Medtronic Frequently Asked Questions

Should I buy or sell Medtronic stock right now?

21 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Medtronic in the last year. There are currently 10 hold ratings and 11 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Medtronic stock.
View analyst ratings for Medtronic
or view top-rated stocks.

What is Medtronic's stock price forecast for 2022?

21 brokerages have issued 1-year target prices for Medtronic's shares. Their MDT stock forecasts range from $100.00 to $165.00. On average, they predict Medtronic's share price to reach $121.55 in the next year. This suggests a possible upside of 33.0% from the stock's current price.
View analysts' price targets for Medtronic
or view top-rated stocks among Wall Street analysts.

How has Medtronic's stock price performed in 2022?

Medtronic's stock was trading at $103.45 at the start of the year. Since then, MDT shares have decreased by 11.7% and is now trading at $91.38.
View the best growth stocks for 2022 here
.

When is Medtronic's next earnings date?

Medtronic is scheduled to release its next quarterly earnings announcement on Tuesday, August 23rd 2022.
View our earnings forecast for Medtronic
.

How were Medtronic's earnings last quarter?

Medtronic plc (NYSE:MDT) announced its quarterly earnings data on Thursday, May, 26th. The medical technology company reported $1.52 earnings per share for the quarter, missing analysts' consensus estimates of $1.56 by $0.04. The medical technology company had revenue of $8.09 billion for the quarter, compared to the consensus estimate of $8.43 billion. Medtronic had a net margin of 15.90% and a trailing twelve-month return on equity of 14.50%. The business's quarterly revenue was down 1.2% compared to the same quarter last year. During the same quarter last year, the business earned $1.50 earnings per share.
View Medtronic's earnings history
.

How often does Medtronic pay dividends? What is the dividend yield for Medtronic?

Medtronic declared a quarterly dividend on Wednesday, May 25th. Stockholders of record on Friday, June 24th will be paid a dividend of $0.68 per share on Friday, July 15th. This represents a $2.72 annualized dividend and a yield of 2.98%. The ex-dividend date is Thursday, June 23rd. This is an increase from Medtronic's previous quarterly dividend of $0.63.
View Medtronic's dividend history
.

Is Medtronic a good dividend stock?

Medtronic(NYSE:MDT) pays an annual dividend of $2.72 per share and currently has a dividend yield of 2.98%. Medtronic has been increasing its dividend for 46 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio of Medtronic is 72.92%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Medtronic will have a dividend payout ratio of 45.11% next year. This indicates that Medtronic will be able to sustain or increase its dividend.
View Medtronic's dividend history.

What guidance has Medtronic issued on next quarter's earnings?

Medtronic issued an update on its FY 2023 earnings guidance on Thursday, June, 23rd. The company provided EPS guidance of $5.53-$5.65 for the period, compared to the consensus EPS estimate of $5.82. The company issued revenue guidance of -.

Who are Medtronic's key executives?

Medtronic's management team includes the following people:
  • Mr. Geoffrey Straub Martha, Chairman & CEO (Age 52, Pay $4.09M)
  • Ms. Karen L. Parkhill, EVP, CFO, IT & Enterprise Excellence (Age 57, Pay $3.29M) (LinkedIn Profile)
  • Mr. Robert John White, Exec. VP & Pres of Medical Surgical Portfolio (Age 59, Pay $2.66M) (LinkedIn Profile)
  • Mr. Mark Ploof, Sr. VP of Global Operations and Bus. Services
  • Ms. Jennifer M. Kirk, Principal Accounting Officer, Global Controller & Chief Accounting Officer (Age 47)
  • Dr. Laura Mauri M.D., M.Sc., Sr. VP and Chief Scientific, Medical & Regulatory Officer
  • Mr. Sean Lennon, Chief Information Officer
  • Mr. Ryan Weispfenning, VP of Investor Relations
  • Mr. Ivan K. Fong, Exec. VP, Gen. Counsel & Sec. (Age 61)
  • Mr. Torod B. Neptune, Sr. VP & Chief Communications Officer

What is Omar S. Ishrak's approval rating as Medtronic's CEO?

1,925 employees have rated Medtronic CEO Omar S. Ishrak on Glassdoor.com. Omar S. Ishrak has an approval rating of 92% among Medtronic's employees. This puts Omar S. Ishrak in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Medtronic own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Medtronic investors own include Johnson & Johnson (JNJ), AT&T (T), NVIDIA (NVDA), AbbVie (ABBV), Walt Disney (DIS), Cisco Systems (CSCO), Intel (INTC), CVS Health (CVS), Home Depot (HD) and Walmart (WMT).

What is Medtronic's stock symbol?

Medtronic trades on the New York Stock Exchange (NYSE) under the ticker symbol "MDT."

Who are Medtronic's major shareholders?

Medtronic's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Chemung Canal Trust Co. (0.01%) and Insight Wealth Strategies LLC (0.00%). Company insiders that own Medtronic stock include Bradley E Lerman, Brett A Wall, Brett A Wall, Carol A Surface, Carol A Surface, Geoffrey Martha, Hoedt Rob Ten, Hooman Hakami, John R Liddicoat, Karen L Parkhill, Karen L Parkhill, Michael J Coyle, Omar Ishrak, Richard H Anderson, Richard H Anderson, Richard Kuntz, Robert John White and Sean Salmon.
View institutional ownership trends for Medtronic
.

Which major investors are buying Medtronic stock?

MDT stock was acquired by a variety of institutional investors in the last quarter, including Chemung Canal Trust Co., and Insight Wealth Strategies LLC.
View insider buying and selling activity for Medtronic
or or view top insider-buying stocks.

How do I buy shares of Medtronic?

Shares of MDT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Medtronic's stock price today?

One share of MDT stock can currently be purchased for approximately $91.38.

How much money does Medtronic make?

Medtronic (NYSE:MDT) has a market capitalization of $122.59 billion and generates $31.69 billion in revenue each year. The medical technology company earns $5.04 billion in net income (profit) each year or $3.73 on an earnings per share basis.

How many employees does Medtronic have?

Medtronic employs 95,000 workers across the globe.

When was Medtronic founded?

Medtronic was founded in 1949.

How can I contact Medtronic?

Medtronic's mailing address is 20 ON HATCH LOWER HATCH STREET, DUBLIN L2, D02. The official website for Medtronic is www.medtronic.com. The medical technology company can be reached via phone at (531) 438-1700, via email at investor.relations@medtronic.com, or via fax at 763-514-4879.

This page (NYSE:MDT) was last updated on 7/5/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.